BLUE bluebird bio

Short Interest in Bluebird Bio, Inc. (NASDAQ:BLUE) Increases By 13.3%

bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 15,190,000 shares, a

01:42

SG Americas Securities LLC Has $59,000 Position in bluebird bio, Inc. (NASDAQ:BLUE)

SG Americas Securities LLC cut its position in bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) by 46.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The

08-15 16:21

Bluebird Bio call volume above normal and directionally bullish

Bullish option flow detected in Bluebird Bio with 7,937 calls trading, 2.0x expected, and implied vol increasing over 1 point to 175.54%. Aug-22 5 calls and Aug-22 7.5 calls are the most active option

08-13 12:05

Catalyst watch: Tim Hortons China debut, FuboTV event and Foot Locker earnings

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events

08-13 03:08

bluebird bio (NASDAQ:BLUE) Trading Up 12.6%

bluebird bio, Inc. (NASDAQ:BLUE – Get Rating)'s share price was up 12.6% during mid-day trading on Thursday . The company traded as high as $6.76 and last traded at $6.68. Approximately 174,236 share

08-12 00:51

Head-To-Head Survey: bluebird bio (NASDAQ:BLUE) and Vaxart (NASDAQ:VXRT)

bluebird bio (NASDAQ:BLUE – Get Rating) and Vaxart (NASDAQ:VXRT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the

08-11 00:21

Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US

Barclays says that CRISPR Therapeutics AG's (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical programs, including the goal of on-track reg

08-10 03:30

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

Gainers Verona Pharma plc (NASDAQ:VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD

08-10 01:30

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket

Gainers BIMI International Medical Inc. (NASDAQ:BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.Ontrak, Inc. (NASDAQ:OTRK) shares r

08-09 17:50

Andrew Obenshain Sells 21,805 Shares of bluebird bio, Inc. (NASDAQ:BLUE) Stock

bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) CEO Andrew Obenshain sold 21,805 shares of the company's stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $4.

08-09 07:11